Business
Eli Lilly hikes sales outlook, as CEO says there's room for 'dramatic' obesity market expansion
CNBC·October 29, 2026
Eli Lilly reported that sales of obesity drug Zepbound and diabetes treatment Mounjaro surged again in the third quarter.
Read the full story at CNBC →